Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

The treatment temporarily improved symptoms of hyperandrogenism in adolescents.

Finasteride significantly reduces the risk of prostate cancer.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Dutasteride-containing mesotherapy effectively treats female hair loss, improving density and thickness with minimal side effects.

Finasteride may affect PNMT, causing side effects.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

1 mg/day of low-dose oral minoxidil is effective and safe for treating female hair loss.

Photobiomodulation did not significantly improve hair density in dogs with alopecia X.

The assay effectively detects hormonal activity of certain chemicals.

Numerical methods help analyze alopecia drugs' properties effectively.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Sonidegib and vismodegib have different side effects and reporting patterns.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

USPlus®Derm may help hair growth and maintain stem cells in male pattern hair loss.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Finasteride slightly improves prostate symptoms but has minimal difference from placebo.

Canine hair follicle cells metabolize DHEA and testosterone differently than human cells.

Metabolic syndrome reduces effectiveness of hair loss treatment.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

New method accurately measures finasteride in tablets.